Evidence map›Paper›PMID 24298015›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

The role of NOD2 in murine and human melioidosis.

Nicolle D Myers, Narisara Chantratita, William R Berrington, Wirongrong Chierakul, Direk Limmathurotsakul, Vanaporn Wuthiekanun, Johanna D Robertson, H Denny Liggitt, Sharon J Peacock, Shawn J Skerrett and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Burkholderia pseudomallei and melioidosis.Nature reviews. Microbiology · 2024
    Review
  3. Article
  4. Longitudinal profiling of plasma cytokines in melioidosis and their association with mortality: a prospective cohort study.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2020
    Article
  5. Human Melioidosis.Clinical microbiology reviews · 2020
    Review
  6. An Evolutionary Arms Race BetweenFrontiers in microbiology · 2020
    Review
  7. Melioidosis.Nature reviews. Disease primers · 2018
    Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Nicolle D MyersDivision of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195;
Narisara Chantratita
William R Berrington
Wirongrong Chierakul
Direk Limmathurotsakul
Vanaporn Wuthiekanun
Johanna D Robertson
H Denny Liggitt
Sharon J Peacock
Shawn J Skerrett
T Eoin West
University of Washington · USMahidol University · THAddenbrooke's Hospital · GBMahidol Oxford Tropical Medicine Research Unit · TH

Funding

Variation in Human Innate ImmunityU54AI057141 · NIAID · UNIVERSITY OF WASHINGTON · PI MOUGOUS, JOSEPH DAVID · 2003 to 2013
$102.3M
Institute of Translational Health SciencesUL1TR000423 · NCATS · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2012 to 2016
$49.4M
Pulmonary Pathogen-Recognition Pathways in MelioidosisK08HL094759 · NHLBI · UNIVERSITY OF WASHINGTON · PI WEST, TIMOTHY EOIN · 2009 to 2013
$637k
The Role of Nod1 and Nod2 in the Pathogeneisis of Legionella Pneumophila PneumoniK08AI080952 · NIAID · UNIVERSITY OF WASHINGTON · PI BERRINGTON, WILLIAM RICHARD · 2009 to 2012
$623k
NCATS NIH HHS UL1 TR000423NCATS NIH HHS UL1TR000423NHLBI NIH HHS K08 HL094759NHLBI NIH HHS K08HL094759NHLBI NIH HHS L30 HL115657NIAID NIH HHS K08 AI080952NIAID NIH HHS K08AI080952NIAID NIH HHS U54 AI057141NIAID NIH HHS U54AI057141Wellcome Trust 087769Wellcome Trust 087769/Z/08/Z
6 · The paper itself

Abstract

Nucleotide-binding oligomerization domain 2 (NOD2) is a cytosolic pathogen recognition receptor that regulates susceptibility to a variety of infections and chronic diseases. Burkholderia pseudomallei, a facultative intracellular bacterium, causes the tropical infection melioidosis. We hypothesized that NOD2 may participate in host defense in melioidosis. We performed a series of in vitro assays and in vivo experiments and analyzed the association of human genetic variation with infection to delineate the contribution of NOD2 to the host response to B. pseudomallei. We found that transfection with NOD2 mediated NF-κB activation induced by B. pseudomallei stimulation of HEK293 cells. After low-dose inoculation with aerosolized B. pseudomallei, Nod2-deficient mice showed impaired clinical responses and permitted greater bacterial replication in the lung and dissemination to the spleen compared with wild-type mice. IL-6 and KC levels were higher in the lungs of Nod2-deficient mice. In a cohort of 1562 Thai subjects, a common genetic polymorphism in the NOD2 region, rs7194886, was associated with melioidosis, and this effect was most pronounced in women. rs7194886 was not associated with differences in cytokine production induced by whole-blood stimulation with the NOD2 ligand, muramyl dipeptide, or B. pseudomallei. To our knowledge, these findings are the first to characterize the role of NOD2 in host defense in mammalian melioidosis.

Indexed as

AnimalsBurkholderia pseudomalleiCell Line, TumorCytokinesDisease Models, AnimalHEK293 CellsHumansImmunity, InnateInterleukin-6LungMelioidosisMiceMice, KnockoutNod2 Signaling Adaptor ProteinPolymorphism, Single NucleotideCytokinesInterleukin-6Nod2 Signaling Adaptor Protein

Identifiers

PMID24298015
PMCPMC3872087
OpenAlexW1536988429

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.